I'll work through this step-by-step for A2A ENERGIA S.P.A. ## Step 1: Identify the Relevant Industry A2A ENERGIA S.P.A. is an Italian multi-utility company. Looking at the provided methodologies: - The company operates in electricity and gas markets - It's described as "A2A ENERGIA S.P.A." with parent "A2A S.p.A." - The entity is involved in energy (power and gas) with both regulated and unregulated activities Based on the sector descriptions, this falls under **"Unregulated Power And Gas"** primarily, but also has regulated utility characteristics. Given the Italian energy market structure and A2A's profile as an integrated multi-utility with generation, distribution, and supply activities, I'll apply the **Unregulated Power And Gas** methodology as the primary framework, with attention to any regulated utility adjustments. However, looking more carefully at A2A's structure - it's a major Italian multi-utility with significant regulated network activities (distribution) as well as unregulated generation and supply. The methodology states that if companies derive significant portions from regulated activities, we need to consider that. For this analysis, I'll use the **general corporate baseline formulas** with appropriate adjustments from the methodologies, particularly noting that A2A has both regulated and unregulated activities. Given the mixed nature, I'll apply the baseline formulas with relevant sector adjustments. ## Step 2: Estimate Adjusted_EBITDA **Baseline formula:** Adjusted_EBITDA = EBITDA (reported or reconstructed) + adjustment_leases (if any) + nonrecurring_losses - nonrecurring_gains ± pension_adjustments ± joint_venture_proportional_EBITDA ± other_normalization_adjustments From the data: - "Gross Operating Income EBITDA" 2022: **1,505,000,000 EUR** - "Result From Nonrecurring Transactions" 2022: **157,000,000 EUR** (positive = gain) For nonrecurring items: The 157M is a positive result (gain). Per S&P methodology, we remove nonrecurring gains: -157,000,000 For pension adjustments: Looking at the data, we have: - "Noncurrent Provisions For Employee Benefits" 2022: 294,000,000 EUR - "Noncurrent Provisions For Employee Benefits" 2023: 248,000,000 EUR - IAS19 reserves in equity changed by 22,000,000 EUR (positive) The pension adjustment typically involves adding back pension costs or adjusting for defined benefit plan impacts. Looking at the comprehensive income, there was a 22M gain on remeasurements of defined benefit plans (net of tax). For EBITDA adjustment, we typically look at service costs vs. interest costs. Without detailed pension cost breakdown, and given the relatively small size, I'll note this but may not make a major adjustment. For joint ventures: "Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method" = 2,000,000 EUR. This is already below EBITDA line, so for EBITDA reconstruction from operating profit, we'd add it back. But since we start with reported EBITDA, this is already included appropriately. For leases: The company has "Payments Of Lease Liabilities Classified As Financing Activities" = 11,000,000 EUR. Under IFRS 16, leases are typically already capitalized on balance sheet. Looking at the expense breakdown, we need to check if lease expenses are already in EBITDA or need adjustment. Given IFRS 16 adoption, operating lease expenses are typically not in EBITDA (they're depreciation/interest). The 11M payment is a financing outflow. Looking for lease-related expenses in operating expenses - not explicitly broken out. I'll assume IFRS 16 is applied and no major lease adjustment needed to EBITDA unless we need to add back lease depreciation. Actually, under S&P methodology for IFRS 16 companies, we typically need to consider if we should add back lease-related depreciation to get to a "pre-IFRS 16" like EBITDA or keep as is. Standard practice now with IFRS 16 is to work with reported EBITDA and treat lease liabilities as debt. Let me reconstruct EBITDA from operating profit to verify: - "Profit Loss From Operating Activities" 2022: 687,000,000 EUR - "Depreciation Amortization Provisions And Writedowns" 2022: 818,000,000 EUR Reported EBITDA = 687M + 818M = 1,505M ✓ matches reported EBITDA Now for Adjusted_EBITDA: - Start with reported EBITDA: 1,505,000,000 - Less nonrecurring gains: -157,000,000 (remove the nonrecurring gain) Adjusted_EBITDA = 1,505,000,000 - 157,000,000 = **1,348,000,000 EUR** Wait - let me re-check. The "Result From Nonrecurring Transactions" is 157M positive. Is this included in operating profit or below? Looking at the structure: - Operating profit: 687M - Then "Result From Nonrecurring Transactions": 157M - Then finance items, etc. So the 157M nonrecurring is BELOW operating profit. Let me recalculate: From the P&L structure: - Profit Loss From Operating Activities: 687,000,000 - Result From Nonrecurring Transactions: 157,000,000 - Finance Income: 35,000,000 - Finance Costs: -125,000,000 - Share Of Profit Loss Of Associates: 2,000,000 - Total Financial Balance: -88,000,000 So EBITDA = Operating Profit + D&A = 687M + 818M = 1,505M The 157M nonrecurring is separate from operating profit. So it's not in EBITDA. But wait - is the 157M included in operating profit? Let me check: "Profit Loss From Operating Activities" is 687M, and then "Result From Nonrecurring Transactions" is shown separately. So operating profit is "clean" of nonrecurring items. Actually, looking more carefully at typical Italian annual report structure, "Result From Nonrecurring Transactions" might be part of EBIT or separate. The sequence suggests: - Operating profit (EBIT before nonrecurring): 687M? Or is this EBIT? In Italian reporting, "Risultato della gestione operativa" or similar might include or exclude nonrecurring. Looking at the labels: "Profit Loss From Operating Activities" then "Result From Nonrecurring Transactions" - this suggests operating profit excludes nonrecurring. So EBIT = 687M + 157M = 844M? Or is 687M already the total EBIT? Let me recalculate: If EBITDA = 1,505M and D&A = 818M, then EBIT = 1,505M - 818M = 687M. So "Profit Loss From Operating Activities" = EBIT = 687M. Then "Result From Nonrecurring Transactions" 157M is likely part of a different section, perhaps financial or extraordinary. Looking at the total: 687M + 157M - 88M (financial balance) = 756M PBT. Yes: 687 + 157 - 88 = 756. ✓ So the 157M nonrecurring is ABOVE the line for PBT but not in operating profit/EBIT. It's an extraordinary or non-operating item. For S&P Adjusted_EBITDA, we want normalized operating performance. The 157M nonrecurring gain should be excluded as it's not recurring operating performance. But is it in EBITDA? No, because it's below EBIT (687M) and EBITDA is 1,505M. Wait, let me re-read: EBITDA is "Gross Operating Income EBITDA" = 1,505M. This is before D&A. EBIT is 687M. The nonrecurring 157M is after EBIT. So: EBITDA 1,505M - D&A 818M = EBIT 687M. Then + nonrecurring 157M = some subtotal, then financial items = PBT 756M. Actually 687M + 157M - 88M = 756M. But the sign on "Total Financial Balance" is -88M (negative). So 687 + 157 - 88 = 756. ✓ matches PBT. So nonrecurring is NOT in EBITDA. Therefore, for Adjusted_EBITDA, we don't need to remove it from EBITDA (it's already excluded). But wait - S&P wants to normalize. If the 157M is nonrecurring and not in EBITDA, should we add it? No, because it's a gain and it's not in EBITDA. For a conservative S&P approach, we don't add nonrecurring gains. However, let me check if there are nonrecurring items IN the EBITDA. Looking at "Other Expense By Nature" = 394M and "Operating Expense" structure. The "Adjustments For Losses Gains On Disposal Of Noncurrent Assets" in cash flow is -191M (negative = gain). This 191M gain on disposal is likely in operating profit/EBITDA. Looking at cash flow adjustments: - "Adjustments For Losses Gains On Disposal Of Noncurrent Assets": -191,000,000 (negative means gain) This 191M gain is likely included in EBITDA. The "Result From Nonrecurring Transactions" 157M might be part of this or separate. Actually, let me look more carefully. The cash flow shows: - Adjustments For Losses Gains On Disposal Of Noncurrent Assets: -191M This suggests there was a 191M gain on disposal included in profit that needs to be adjusted out in cash flow (hence negative adjustment = subtract the gain). Where is this in P&L? It might be in "Other Revenue" or part of operating profit, or in the 157M nonrecurring. Given the complexity, let me use a different approach. S&P typically focuses on sustainable operating cash generation. The 157M "Result From Nonrecurring Transactions" - if this is nonrecurring, we exclude it. But it's not in EBITDA. Actually, re-reading: "Result From Nonrecurring Transactions" of 157M is likely a separate line item. For S&P purposes, we want to normalize EBITDA. If there are nonrecurring gains in EBITDA, we remove them; if nonrecurring losses, we add them back. Looking at the cash flow adjustments for noncash items: - Adjustments For Losses Gains On Disposal Of Noncurrent Assets: -191M (gain to remove) - Adjustments For Impairment Loss Reversal: 10M (impairment to add back) - Adjustments For Provisions: 92M (add back provisions) These are all below EBITDA in the cash flow reconciliation (from net profit to operating cash flow). Let me reconstruct from the cash flow: Net profit: 448M + D&A: 491M + 233M = 724M (but wait, total D&A in P&L note is 818M, which includes more than just depreciation and amortization - it includes provisions and writedowns) Actually "Depreciation Amortization Provisions And Writedowns" = 818M total. But cash flow shows: - Depreciation Expense: 491M - Amortisation Expense: 233M - Adjustments For Impairment Loss Reversal Of Impairment Loss: 10M - Adjustments For Provisions: 92M Total: 491 + 233 + 10 + 92 = 826M, close to 818M (small differences likely due to other items). For Adjusted_EBITDA, I'll use: - Reported EBITDA: 1,505M - The 157M nonrecurring is NOT in EBITDA (it's after EBIT) - Check if there are other nonrecurring items in EBITDA Actually, I need to be more careful. Let me look at whether "Gross Operating Income EBITDA" includes or excludes nonrecurring. In Italian financial reporting, "Risultato Operativo Lordo" (Gross Operating Income) typically excludes nonrecurring items, which are shown separately. Given that "Result From Nonrecurring Transactions" is shown separately after "Profit Loss From Operating Activities", this confirms that operating profit/EBITDA excludes nonrecurring. However, S&P methodology wants to see if there are "hidden" nonrecurring items in EBITDA. The cash flow adjustment for disposal gains (-191M) suggests there was a significant gain. Where is this? Looking at the P&L: "Other Revenue" is 220M in 2022 vs 197M in 2021. This increase might include some nonrecurring items. Given the information available, I'll make the following adjustments to EBITDA: - Remove nonrecurring gains: The 157M is not in EBITDA, so no adjustment needed there - But the 191M gain on disposal (per cash flow) - need to check if in EBITDA Actually, looking more carefully at cash flow: "Adjustments For Losses Gains On Disposal Of Noncurrent Assets" = -191M. This is an adjustment FROM net profit TO operating cash flow. Negative means the gain was included in net profit and we subtract it to get to cash flow. Since this gain is likely in "Result From Nonrecurring Transactions" (157M) or part of operating profit, and since operating profit is 687M while EBITDA is 1505M, the gain could be anywhere. Given uncertainty, let me take a conservative approach: use reported EBITDA and make minimal adjustments. The key S&P adjustment is typically to normalize for nonrecurring items. Actually, let me re-examine: "Result From Nonrecurring Transactions" 157M - this might be the net of various nonrecurring items including the 191M gain and other losses. For S&P, we want sustainable EBITDA. I'll: - Start with 1,505M - Make no adjustment for the 157M (it's not in EBITDA) - But check if we need pension or other adjustments For pensions: The IAS19 reserve change was +22M (gain). This is an actuarial gain in OCI, not in P&L typically. The pension expense in P&L would be service cost + interest cost. Without detailed breakdown, I'll assume the 294M provision is reasonable. For JVs: The 2M equity pickup is below EBITDA line, so no EBITDA adjustment needed. **Adjusted_EBITDA = 1,505,000,000 EUR** Wait - I should reconsider. The S&P methodology for unregulated power and gas may want us to look at "underlying" performance. Let me check if the 157M nonrecurring should be treated differently. Actually, re-reading the formula: "nonrecurring_losses - nonrecurring_gains". If the 157M is a nonrecurring gain not in EBITDA, we don't subtract it (it's already excluded). But if there are nonrecurring losses that were excluded, we'd add them back. Given the positive 157M is a "Result From Nonrecurring Transactions" (gain), and it's excluded from operating profit, the EBITDA is already "clean". However, I want to check one more thing: is there any nonrecurring IN the EBITDA? The large increase in revenue from 11,352M to 22,946M suggests significant market volatility (likely energy price spikes in 2022). This is largely pass-through in nature for an energy supplier. For an energy company like A2A, the 2022 revenue spike is due to commodity prices. The "Raw Materials And Consumables Used" went from 9,088M to 20,502M, confirming pass-through nature. The EBITDA margin compressed: 1,505/23,166 = 6.5% in 2022 vs 1,428/11,549 = 12.4% in 2021. For S&P, they might view this as somewhat normalized already, or they might adjust for working capital distortions. Let me proceed with Adjusted_EBITDA = 1,505M and note we may need to revisit. Actually, I realize I should check if lease adjustments are needed. Under IFRS 16, lease depreciation is part of D&A and lease interest is part of finance costs. EBITDA includes the "lease expense" as depreciation is added back. So IFRS 16 EBITDA is higher than old IAS 17 EBITDA. For S&P, when comparing to historical metrics or for ratio purposes, they sometimes adjust. But for current calculation, we'll use reported figures. Let me also check the 191M disposal gain more carefully. If it's in "Result From Nonrecurring Transactions" (157M), then there's a mismatch. Perhaps the 191M is gross and 157M is net of other items, or perhaps they're in different places. Given: "Disposal Of Fixed Assets And Shareholdings" in investing activities = 413M. This is cash proceeds. The gain would be 413M - book value. If book value was 222M, gain is 191M. This seems reasonable. Where is this 191M gain in P&L? It could be in operating profit or nonrecurring. Since "Result From Nonrecurring Transactions" is only 157M, and 191M > 157M, perhaps there are offsetting losses, or the gain is partly in operating profit. For conservatism, if the 191M gain is in operating profit/EBITDA, we should remove it. But we don't know for sure. Let me try: if EBITDA includes 191M gain, and "Result From Nonrecurring Transactions" is 157M (which might include other items), then Adjusted_EBITDA = 1,505M - 191M = 1,314M? But this might double-count if the 191M is already in the 157M. Given the uncertainty and that 157M < 191M, let me assume the 157M is the net nonrecurring result after some offsets, and it's shown separately from operating profit. Thus EBITDA is clean. **Final Adjusted_EBITDA = 1,505,000,000 EUR** Actually, I want to reconsider one more time. Looking at the cash flow reconciliation more carefully: From net profit (448M) to operating cash flow (1,260M): + D&A and impairments/provisions: ~826M + Other adjustments: various working capital = 1,260M The -191M gain on disposal is an adjustment in this reconciliation. Since net profit includes the 157M nonrecurring (gain), and the -191M is a further adjustment, this suggests the 191M is also in net profit but maybe in a different place. Actually, let me trace: Net profit 448M includes: - Operating profit related: 687M EBITDA - 818M D&A = 687M EBIT... wait this doesn't work. Let me recalculate. EBITDA = 1,505M - D&A (including provisions/writedowns) = 818M = EBIT = 687M + Nonrecurring = 157M + Financial balance = -88M = PBT = 756M - Tax = 344M = Continuing operations = 412M + Discontinued operations = 36M = Net profit = 448M Now, the 191M gain on disposal: where is it? It could be part of the 157M nonrecurring. But 191M > 157M, so perhaps there were losses elsewhere, or the 191M is partly in operating profit. Actually, "Adjustments For Losses Gains On Disposal Of Noncurrent Assets" = -191M in cash flow. This means: in the reconciliation from net profit to operating cash flow, we SUBTRACT 191M (because it was a gain included in net profit but not operating cash flow). If the 191M gain is in the 157M "Result From Nonrecurring Transactions", then when we do cash flow reconciliation, we'd subtract it. But the 157M is already in PBT. So the cash flow adjustment would be -157M for nonrecurring, not -191M. The fact that it's -191M specifically for "Disposal Of Fixed Assets And Shareholdings" suggests this is a separate item from the 157M nonrecurring result, or the 157M is a net figure. Perhaps: 157M "Result From Nonrecurring Transactions" includes various items, and the 191M disposal gain is part of operating profit or shown elsewhere. Given the complexity, I'll make a conservative adjustment: assume the 191M gain is in EBITDA and remove it, but also consider that the 157M might be related. Actually, let me try a different approach. Let's see if 1,505M EBITDA makes sense as sustainable. The EBITDA margin dropped from 12.4% to 6.5%. This is due to commodity price volatility where passthrough wasn't perfect. For 2022, with extreme energy prices, this might actually be somewhat depressed due to regulatory lag or imperfect hedging. For S&P, they might use a normalized EBITDA. But without guidance on normalization, I'll use reported. Let me settle on: **Adjusted_EBITDA = 1,505,000,000 EUR** with potential downward adjustment if we identify nonrecurring gains in EBITDA. Given the -191M adjustment in cash flow for disposal gains, and if we assume these are in EBITDA: Adjusted_EBITDA = 1,505M - 191M = 1,314M But I'm not certain. Let me check if "Disposal Of Fixed Assets And Shareholdings" proceeds of 413M relate to the 191M gain. If book value was 222M, then yes. Where would this gain be recorded? In IFRS, gains on disposal are typically in operating profit or separate line. Given Italian practice, it might be in "Other Revenue" or "Other Income". "Other Revenue" increased from 197M to 220M - not enough for 191M. "Other Current Nonfinancial Assets" decreased from 4,051M to 3,289M - significant change. "Noncurrent Assets" held for sale went from 162M to 0. I think the safest approach is: the 191M gain is likely in the nonrecurring or operating result. Since we can't be certain and S&P typically wants to remove nonrecurring gains, let me adjust EBITDA down by 191M if it's in EBITDA, or leave if it's not. Given "Result From Nonrecurring Transactions" is 157M and is AFTER operating profit, and the 191M is larger than 157M, I think the 191M is likely partly in operating profit/EBITDA. Let me use: **Adjusted_EBITDA = 1,505,000,000 - 191,000,000 = 1,314,000,000 EUR** This is more conservative and aligns with S&P's preference for sustainable earnings. Wait - but I need to check if the 157M nonrecurring is a net figure that already accounts for some of this. Let me see: if total nonrecurring gains are 191M and losses are 34M, net is 157M. Then the 157M shown separately IS the net nonrecurring, and it's after operating profit. So where is the 191M gross gain? It must be in operating profit! Actually, that makes sense: the 191M gain is included in operating profit/EBITDA, and then there are 34M of nonrecurring losses elsewhere, giving net 157M shown separately. But then operating profit would include 191M gain... Let me check: if operating profit 687M includes 191M gain, then underlying operating profit is 496M. EBITDA 1,505M includes 191M gain, so underlying EBITDA is 1,314M. Then the separate 157M is... wait, that doesn't work because 191M - 34M = 157M, but the 157M is shown separately. I think the correct interpretation is: "Result From Nonrecurring Transactions" 157M is the net nonrecurring result, shown separately. The cash flow adjustment -191M is for disposal gains, which might be part of this 157M or separate. Given the cash flow shows -191M for disposal gains and +157M for "Result From Nonrecurring Transactions" in P&L, these are likely the same or related. The difference (191 vs 157) could be due to: - 191M is gross gain, 157M is net after some losses or adjustments - Different items entirely For safety, I'll use the more conservative: remove 191M from EBITDA if it's in there, or just use 1,505M if not. After more thought: the cash flow adjustment -191M is "Adjustments For Losses Gains On Disposal Of Noncurrent Assets". This is clearly for noncurrent asset disposals. The 413M proceeds in investing activities confirms this. In P&L, this would typically be shown as a gain, often in operating profit or as a separate line. Given it's not in "Result From Nonrecurring Transactions" (which is 157M, less than 191M), it might be in operating profit. I'll adjust: **Adjusted_EBITDA = 1,505,000,000 - 191,000,000 = 1,314,000,000 EUR** But wait - I want to double-check. The 157M "Result From Nonrecurring Transactions" - could this include the 191M gain minus some losses? 191M gain - 34M losses = 157M? That would make sense! If so, then the 157M is NET nonrecurring, and it's shown separately from operating profit. The cash flow shows -191M for disposal gains (just one component), and there might be other nonrecurring items. Actually, re-reading: "Adjustments For Losses Gains On Disposal Of Noncurrent Assets" = -191M. This is just one type of nonrecurring. "Result From Nonrecurring Transactions" = 157M is the total net nonrecurring. If 157M is the total and it's separate from operating profit, then operating profit/EBITDA is clean of nonrecurring. The -191M in cash flow would then need to be reconciled: perhaps the 157M includes +191M gain and -34M other losses, but shown as net 157M. In that case, when doing cash flow from net profit, we start with 448M, subtract 157M (nonrecurring), then also subtract 191M? No, that would double-count. I think the correct interpretation is: "Result From Nonrecurring Transactions" 157M is the net figure shown in P&L. The cash flow adjustments break this down: -191M for disposal gains, and presumably other adjustments for other nonrecurring items (like +34M for losses, or other items). Actually, looking at all cash flow adjustments from net profit: - Adjustments For Income Tax Expense: 344M - Net Financial Interests: 90M - Adjustments For Losses Gains On Disposal: -191M - Depreciation: 491M - Amortisation: 233M - Impairment: 10M - Provisions: 92M - Undistributed Profits Of Associates: -2M - Interest Paid: -75M - Income Taxes Paid: -201M - Dividends Paid: -302M - Working capital changes: various - Other adjustments: -512M Total adjustments to get from net profit 448M to operating cash flow 1,260M. The -191M is just one piece. It seems like the 157M "Result From Nonrecurring Transactions" in P&L is separate and the cash flow adjustments work from net profit which includes this 157M. So: Net profit 448M includes +157M nonrecurring. To get to operating cash flow, we need to remove this 157M (or its components). The -191M is part of this removal. Given this, the 157M nonrecurring IS in net profit but NOT in operating profit (since it's shown separately after operating profit). So EBITDA 1,505M is CLEAN. Therefore: **Adjusted_EBITDA = 1,505,000,000 EUR** The -191M cash flow adjustment is removing the cash flow impact of disposals (which are investing, not operating). The gain itself was in nonrecurring, not operating. Wait, but if the gain is in nonrecurring (157M), and we subtract 191M in cash flow, there's a mismatch. Unless the 157M includes other items too. Let me just accept that EBITDA is likely clean and use 1,505M. The cash flow adjustments will sort themselves out. **Adjusted_EBITDA = 1,505,000,000 EUR** ## Step 3: Estimate FFO **Baseline formula:** FFO = Adjusted_EBITDA - cash_interest - cash_taxes From the data: - "Interest Paid Classified As Operating Activities": 75,000,000 EUR - "Income Taxes Paid Refund Classified As Operating Activities": 201,000,000 EUR For cash interest: 75M is paid. But is this all interest? "Net Financial Interests" in cash flow is 90M. "Finance Costs" in P&L is 125M, "Finance Income" is 35M, so net 90M. The 75M paid is cash interest paid. There might be interest received of 35M or other items. For S&P FFO, we use: Adjusted_EBITDA - cash_interest_paid - cash_taxes_paid FFO = 1,505,000,000 - 75,000,000 - 201,000,000 = **1,229,000,000 EUR** But wait - we need to check if there are dividends from JVs or other items to add back. S&P FFO typically includes: - Dividends received from JVs (if equity accounted): "Dividends Received Classified As Investing Activities" = 2M - this is in investing, not operating - Sometimes we add back JV dividends if they're part of FFO Standard S&P FFO: Funds From Operations = Net income + D&A + deferred taxes + other non-cash items - working capital changes... or from EBITDA: EBITDA - cash interest - cash taxes. Actually, looking at S&P's definition more carefully, they often calculate FFO as: FFO = Net income + depreciation + amortization + deferred income taxes + other non-cash items Or from EBITDA: FFO = EBITDA - interest expense (accrual) - current tax expense ± other items But the formula given is: FFO = Adjusted_EBITDA - cash_interest - cash_taxes Using this: FFO = 1,505M - 75M - 201M = 1,229M However, I need to check if we should use "Net Financial Interests" 90M or "Interest Paid" 75M. The formula says cash_interest, so 75M is correct. But also, we need to consider if there are other items. Looking at the cash flow, "Cash Flows From Used In Operating Activities" is 1,260M. This is after all working capital changes and other items. The relationship: Adjusted_EBITDA 1,505M - cash interest 75M - cash taxes 201M = 1,229M. But actual operating cash flow is 1,260M. The difference (31M) is from working capital changes and other items that are part of cash flow but not FFO. Actually, S&P FFO is typically closer to "operating cash flow before working capital changes" or "EBITDA - interest - taxes". The 1,229M seems reasonable. But let me also check: should we use accrual taxes or cash taxes? The formula says cash_taxes, so 201M is correct. However, I want to verify the tax figure. "Income Tax Expense Continuing Operations" is 344M (accrual), but "Income Taxes Paid" is 201M (cash). The difference is due to timing (deferred taxes, payments for prior years, etc.). For FFO, S&P uses cash taxes when going from EBITDA, or adds back deferred taxes when going from net income. **FFO = 1,229,000,000 EUR** Wait - I need to reconsider the Adjusted_EBITDA. If I should have adjusted it down by 191M, then: Adjusted_EBITDA = 1,314M FFO = 1,314M - 75M - 201M = 1,038M Let me think again about whether to adjust. The S&P methodology says "nonrecurring_losses - nonrecurring_gains". If the 191M gain is in EBITDA, we subtract it. Given the cash flow adjustment of -191M for disposal gains, and the fact that "Disposal Of Fixed Assets And Shareholdings" generated 413M cash, this is clearly a real gain. Whether it's in EBITDA depends on where it was recorded. In typical IFRS, gains on disposal of PPE are recorded in operating profit or as separate items. Looking at the P&L structure, there's no separate line for this before "Result From Nonrecurring Transactions". Actually, I think I need to be more careful. "Other Revenue" 220M could include some gains. Or the gain could be netted against "Other Expense By Nature" or "Raw Materials And Consumables Used". Given the uncertainty, and that S&P prefers conservative/sustainable measures, let me adjust for the 191M gain: **Adjusted_EBITDA = 1,505,000,000 - 191,000,000 = 1,314,000,000 EUR** Then: **FFO = 1,314,000,000 - 75,000,000 - 201,000,000 = 1,038,000,000 EUR** Hmm, but I want to check one more thing. The "Result From Nonrecurring Transactions" is 157M. If this is the TOTAL nonrecurring and it's separate from operating profit, then operating profit is clean. But the 191M > 157M creates an issue. Perhaps: 157M is nonrecurring RESULT (net), while 191M is just the gain on disposals. There could be other nonrecurring losses of 34M, making net 157M. But then the 157M is shown separately, and the 191M is... where? I think the most likely is: the 191M gain is IN operating profit/EBITDA, and the 157M "Result From Nonrecurring Transactions" includes other items (perhaps losses or different items). Or the 191M is part of the 157M, and there are presentation differences. Given this confusion, let me try a different approach: use operating cash flow as a check. Operating cash flow 1,260M includes: - Net profit 448M + D&A, impairments, provisions 826M - Gain on disposal -191M + Other adjustments + Working capital changes (receivables, payables, inventory) + Other noncash -512M - Interest paid -75M - Taxes paid -201M - Dividends paid -302M Wait, the dividends paid 302M is classified as operating! That's unusual. S&P typically treats dividends paid as financing, not operating. Let me recalculate from the given: "Cash Flows From Used In Operating Activities" = 1,260M. This includes dividends paid of 302M? That seems odd. Let me check: "Dividends Paid Classified As Operating Activities" = 302M. Actually, in some IFRS presentations, dividends paid can be operating or financing. Here it's operating. For S&P, we might reclassify. But for FFO calculation per the given formula, we don't need to reclassify. Let me try yet another approach: calculate FFO from net income. Net income: 448M + D&A (including impairment, provisions): 491 + 233 + 10 + 92 = 826M (or use 818M from P&L) - Gain on disposal: -191M (or is this already excluded?) + Deferred taxes: ? From P&L: Income tax expense 344M. Cash taxes 201M. So deferred tax benefit/expense = 344M - 201M = 143M expense? Or check: "Net Deferred Tax Assets" changed from 424M to 363M, decrease of 61M. This suggests deferred tax expense of 61M. Actually, "Adjustments For Income Tax Expense" in cash flow is 344M. This adds back the accrual tax expense. Then "Income Taxes Paid" subtracts 201M cash. The difference 143M is deferred/non-cash tax expense or timing differences. For FFO from net income: 448M + 818M (D&A) + 143M (deferred tax) - 191M (gain) + other items = ? This gets complicated. Let me stick with the EBITDA-based approach. Given my uncertainty about the 191M, let me check if there's evidence it's in EBITDA. The "Other Revenue" is 220M, up from 197M. The increase is 23M, not 191M. So the gain is not in "Other Revenue" as a separate line. The gain could be netted against expenses or in a different line. Without clear evidence, and given that "Result From Nonrecurring Transactions" is shown separately and is only 157M, I'll assume EBITDA is clean and the 191M is part of that 157M or otherwise not in EBITDA. **Revised decision: Adjusted_EBITDA = 1,505,000,000 EUR (no adjustment)** Then FFO = 1,505M - 75M - 201M = **1,229,000,000 EUR** Actually, I want to check one more thing. The formula says "cash_interest" not "interest paid classified as operating". Is there interest paid classified as financing? "Payments Of Lease Liabilities Classified As Financing Activities" = 11M. This includes lease principal and interest. But the interest portion is typically small. Also, "Finance Costs" 125M vs "Net Financial Interests" 90M vs "Interest Paid" 75M. The differences are due to accruals, capitalized interest, interest income, etc. For S&P, cash interest paid is typically 75M (from operating) plus any interest paid in financing. The 11M lease payments include some interest, but it's small. I'll use 75M as cash_interest. **FFO = 1,229,000,000 EUR** ## Step 4: Estimate Adjusted_Debt **Baseline formula:** Adjusted_Debt = (reported_debt + leases + pension_deficit + guarantees + hybrid_debt_portion + other_debt_like_items) - eligible_cash First, identify reported debt: - "Other Noncurrent Financial Liabilities" 2022: 4,322,000,000 EUR - "Other Current Financial Liabilities" 2022: 746,000,000 EUR Total reported debt = 4,322M + 746M = 5,068,000,000 EUR For leases: Under IFRS 16, lease liabilities are in financial liabilities. Need to check if separated. The "Payments Of Lease Liabilities Classified As Financing Activities" = 11M suggests there are lease liabilities. But they're likely included in "Other Noncurrent Financial Liabilities" and/or "Other Current Financial Liabilities". For S&P, we typically don't add leases separately if already in reported debt under IFRS 16. But we need to check if they're properly classified as debt. Actually, under IFRS 16, lease liabilities ARE financial liabilities and should be in "Other Financial Liabilities". So the 5,068M likely includes lease debt. For pension deficit: "Noncurrent Provisions For Employee Benefits" = 294M. This is a provision, not necessarily debt-like. For S&P, we assess if there's a pension deficit. The net pension position: We don't have full pension asset/liability details. The provision 294M is a liability. If pension assets exist, they might be in "Other Noncurrent Assets" or elsewhere. Looking at "Other Noncurrent Assets": 25M in 2022, 86M in 2023. Small. "Net Deferred Tax Assets" 424M in 2022 - this includes deferred tax on pension deficits potentially. Without detailed pension asset info, I'll use the provision as a proxy for underfunding, or check if it's debt-like. S&P typically adds pension deficits (liability minus fair value of plan assets). If we don't have plan assets, we might use the liability as a conservative estimate, or look for net position. Given "Noncurrent Provisions For Employee Benefits" = 294M and no obvious pension assets, I'll add this as debt-like. But actually, this is already a provision, not debt. S&P adds pension deficits to debt. Let me check if there's a pension deficit: The IAS19 reserve in equity changed, suggesting defined benefit plans exist. The 294M provision is likely the net liability. If plan assets exist, they're likely not shown separately (netted). I'll conservatively add: **pension deficit = 294,000,000 EUR** (using the provision as proxy, or actual deficit if this is net) Actually, the 294M is "Noncurrent Provisions For Employee Benefits" which is the net liability under IAS 19 (liability minus plan assets). So this is already the deficit. S&P would add this to debt. For guarantees: No specific data. Could be zero or embedded in other liabilities. For hybrid debt: No specific data on hybrid instruments. The equity includes various reserves but no obvious hybrid debt. For other debt-like items: - "Other Longterm Provisions" = 797M - these are operational provisions, not typically debt-like - "Other Noncurrent Liabilities" = 129M - need to check nature - "Other Current Nonfinancial Liabilities" = 4,487M - includes various operational payables For working capital adjustments: S&P sometimes adjusts for seasonal working capital or specific items. For eligible cash: "Cash And Cash Equivalents" = 964,000,000 EUR in 2022. Also check if there's restricted cash. No specific mention. "Other Current Financial Assets" = 9M, small. For S&P, eligible cash is typically cash and liquid investments minus restricted cash. Using 964M. Now, for the debt-like items, I need to consider: - Are "Trade And Other Current Payables To Trade Suppliers" (2,894M) debt? No, these are trade payables, not debt. - Are "Other Current Nonfinancial Liabilities" (4,487M) debt-like? These could include advances, deferred income, taxes payable, etc. Not typically financial debt. Let me focus on financial liabilities: - Noncurrent financial liabilities: 4,322M - Current financial liabilities: 746M Total: 5,068M Plus pension deficit: 294M Less eligible cash: 964M Adjusted_Debt = 5,068M + 294M - 964M = **4,398,000,000 EUR** Wait - I need to check if there are other debt-like items. Let me look at "Other Noncurrent Financial Liabilities" more carefully. This 4,322M likely includes: - Bank loans - Bonds - Lease liabilities - Other financial debt And "Other Current Financial Liabilities" 746M likely includes: - Current portion of long-term debt - Short-term borrowings - Current lease liabilities - Other current financial debt For S&P, we also need to consider if there are debt-like items in "Other Current Nonfinancial Liabilities" or elsewhere. For example, if there are factoring arrangements, securitization, or other off-balance sheet items. Also, the methodology mentions: "Where substantial seasonal working capital requirements--for example, at natural gas distribution utilities--distort leverage measures, we adjust inventory and debt balances by netting the value of inventory against outstanding short-term borrowings." A2A has inventories of 204M and short-term borrowings that might be seasonal. But 204M is relatively small vs 5,068M debt. And the company is not primarily a gas distribution utility (it's multi-utility with generation, supply, networks). For unregulated power and gas: "For unregulated power and gas companies that enter into long-term power purchase agreements (PPAs), we make adjustments to account for those obligations, as we do for regulated utilities under our ratios and adjustments criteria." A2A likely has PPAs. But without specific data on PPA debt-like obligations, I can't quantify this. Also, for working capital: the large increase in "Current Trade Receivables" (3,291M to 4,680M) and "Trade And Other Current Payables" (2,894M to 5,524M) suggests significant working capital changes due to energy price volatility. S&P might make adjustments, but this affects FFO (via working capital in cash flow), not necessarily debt. Let me recalculate with potential adjustments: Reported debt: 5,068M + Pension deficit (net liability): 294M + Other debt-like items: ? Looking at "Other Noncurrent Liabilities" 129M - if these are debt-like (e.g., put options, earn-outs), add them. Without detail, assume operational. "Other Longterm Provisions" 797M - these are typically operational risks, not debt-like. "Other Current Nonfinancial Liabilities" 4,487M - includes VAT, social security, advances, etc. Not debt-like. So: Adjusted_Debt = 5,068M + 294M - 964M = 4,398M But wait - I should check if the 294M pension is already included in debt. "Noncurrent Provisions For Employee Benefits" is a provision, not a financial liability. S&P adds it to debt as a debt-like item. Also, I want to double-check the cash figure. "Cash And Cash Equivalents" 2022-01-01 is 964M (this is beginning of 2022, i.e., end of 2021). For 2022 year-end, it's 2,584M. The question asks for 2022 fiscal year. The data uses 2022-01-01 and 2023-01-01 as balance sheet dates (beginning and end of 2022). So 2022 year-end is 2023-01-01: 2,584M cash. Wait, let me re-read the data format: - "Property Plant And Equipment" 2023-01-01: 6,162M - "Property Plant And Equipment" 2022-01-01: 5,588M So 2022-01-01 is beginning of 2022 (end of 2021), and 2023-01-01 is end of 2022. For debt at end of 2022: - "Other Noncurrent Financial Liabilities" 2023-01-01: 5,867M - "Other Current Financial Liabilities" 2023-01-01: 1,022M Total reported debt at end 2022: 5,867M + 1,022M = 6,889M Cash at end 2022: 2,584M Pension provision at end 2022: 248M So recalculating for end-2022: Adjusted_Debt = 6,889M + 248M - 2,584M = **4,553,000,000 EUR** Wait - but do we use average debt or end-of-period debt? S&P typically uses average debt for ratios, or end-of-period. For FFO/debt, they typically use end-of-period debt or average. The standard is often average debt to smooth fluctuations. But the formula given says "Adjusted_Debt" without specifying. Let me check S&P practice: they typically use "average debt" for interest coverage and "end-of-period" or "average" for FFO/debt depending on context. Actually, for FFO/debt, they usually use end-of-period debt or a combination. Given the formula provided doesn't specify, I'll use end-of-period as it's more common for point-in-time ratios, or perhaps average if there's significant change. Debt changed from 5,068M to 6,889M during 2022. Average = (5,068 + 6,889) / 2 = 5,978.5M Cash changed from 964M to 2,584M. Average = (964 + 2,584) / 2 = 1,774M Pension changed from 294M to 248M. Average = 271M Average Adjusted_Debt = 5,978.5M + 271M - 1,774M = 4,475.5M Or end-of-period = 6,889M + 248M - 2,584M = 4,553M Given S&P typically uses end-of-period for leverage ratios (or sometimes average), and the problem doesn't specify, I'll use end-of-period as it's more conservative with increasing debt. Actually, re-reading S&P methodology: they often use "adjusted debt" at period end for point-in-time measures, or average for interest coverage. For FFO/debt, I believe they typically use end-of-period debt or a hybrid. Let me use end-of-period: **Adjusted_Debt = 4,553,000,000 EUR** But I want to check one more thing. Should we use beginning or end period for the balance sheet when calculating 2022 ratios? The FFO is a flow for 2022, so debt should be the average or end-of-period to match. Actually, looking at S&P's standard practice more carefully: for FFO/debt, they typically use end-of-period debt (or sometimes average of beginning and end). Using end-of-period is more common when debt has increased, as it gives a more current picture. However, some S&P calculations use "average" debt to better match the flow measure with the stock measure. Let me check if there's guidance. Given no specific guidance in the problem, I'll use end-of-period as it's simpler and more commonly cited. But I'll note that average would give 4,476M. Wait - I need to re-check. The problem asks for "2022" ratio. In S&P terminology, this typically means using 2022 FFO and 2022 year-end debt. Using end-2022: Adjusted_Debt = 6,889M + 248M - 2,584M = 4,553M ## Step 5: Calculate FFO / Adjusted_Debt Using: - FFO = 1,229,000,000 EUR - Adjusted_Debt = 4,553,000,000 EUR FFO / Adjusted_Debt = 1,229 / 4,553 = **0.2699** Or about 27.0%. Let me double-check with potential variations: If I used Adjusted_EBITDA = 1,314M (with 191M adjustment): FFO = 1,314M - 75M - 201M = 1,038M FFO / Adjusted_Debt = 1,038 / 4,553 = 0.2280 If I used average debt (4,476M): FFO / Adjusted_Debt = 1,229 / 4,476 = 0.2746 Or with both adjustments: 1,038 / 4,476 = 0.2319 Given my uncertainty about the 191M, let me reconsider. The cash flow adjustment of -191M for "Disposal Of Fixed Assets And Shareholdings" is clearly removing a gain. But where was this gain recorded? Looking at the P&L again: "Result From Nonrecurring Transactions" = 157M. If this is the net nonrecurring result and it's separate from operating profit, then operating profit/EBITDA is clean. But then why is the cash flow adjustment -191M and not -157M? Because the cash flow adjustment is for the specific item "Disposal Of Fixed Assets And Shareholdings" which is 191M. The 157M "Result From Nonrecurring Transactions" might include this 191M gain minus other nonrecurring losses of 34M. Wait, that math works: 191M gain - 34M losses = 157M net. But then the cash flow would show -191M for disposals and +34M for other losses (or the losses are non-cash). Actually, looking at cash flow adjustments: "Adjustments For Losses Gains On Disposal Of Noncurrent Assets" = -191M. There might be other adjustments for other nonrecurring items. If the 157M is the NET nonrecurring shown in P&L, and it's separate from operating profit, then: - Operating profit 687M is clean - + 157M nonrecurring = 844M subtotal - - 88M financial = 756M PBT The 191M disposal gain is part of the 157M nonrecurring. So it's NOT in operating profit/EBITDA. Therefore, **EBITDA is clean at 1,505M**. But wait, let me verify with the cash flow. If net profit 448M includes 157M nonrecurring, and we want operating cash flow, we need to remove nonrecurring items. The cash flow shows: - Start with net profit 448M - Add back D&A, etc. - Subtract 191M disposal gain (because it's non-operating/investing) - Add back other nonrecurring losses if any - etc. The -191M is specifically for disposal gains. If there are other nonrecurring losses of 34M, they might be added back (positive adjustment). Looking through the cash flow adjustments, I see various items but no clear +34M for other nonrecurring. Actually, "Other Adjustments For Noncash Items" = 225M in 2021 and -512M in 2022. This large negative in 2022 might include various items, possibly netting the nonrecurring. Given the complexity, I'll trust that EBITDA is clean and use 1,505M. **Final calculation:** - Adjusted_EBITDA = 1,505,000,000 EUR - FFO = 1,505M - 75M - 201M = 1,229,000,000 EUR - Adjusted_Debt (end 2022) = 6,889M + 248M - 2,584M = 4,553,000,000 EUR - FFO / Adjusted_Debt = 1,229 / 4,553 = 0.2699... Let me calculate more precisely: 1,229 / 4,553 = 0.269931... Rounded to four decimal places: **0.2699** Actually, I want to check one more thing about debt. Should I include "Noncurrent Provisions For Employee Benefits" as debt-like? S&P does add pension deficits. But is 248M the deficit or the gross liability? Under IAS 19, the balance sheet shows the net position (funded status). If plan assets exceed liabilities, it's an asset; if liabilities exceed assets, it's a liability. The "Noncurrent Provisions For Employee Benefits" 248M is likely the net liability (deficit). S&P adds this to debt. But let me check if there are plan assets elsewhere. "Other Noncurrent Assets" 86M includes various items. "Other Noncurrent Financial Assets" 70M. These are small compared to 248M. I'll keep the pension deficit at 248M. Also, I want to verify: are there any hybrid securities? Looking at equity: - Issued Capital: 1,629M - Reserves: 1,869M - Result of the Year: 401M - Noncontrolling Interests: 568M No obvious hybrid instruments in equity. So no hybrid adjustment. One more check: should I add back dividends paid in operating activities? S&P sometimes treats dividends as financing, not operating. The 302M dividends paid are classified as operating in this cash flow. If we reclassify to financing, FFO would increase by 302M. But the given formula is: FFO = Adjusted_EBITDA - cash_interest - cash_taxes. It doesn't mention dividends. So I'll follow the formula. However, S&P's standard FFO definition sometimes includes dividends received from JVs but excludes dividends paid (which are financing). The 2M dividends received are in investing activities. For strict adherence to the given formula: FFO = 1,505M - 75M - 201M = 1,229M. But if we think about sustainable cash generation, should we subtract dividends paid? The formula doesn't say so. And S&P FFO is typically before dividends. Actually, let me re-read S&P's standard FFO definition. In their corporate methodology, FFO is typically: FFO = Funds from operations = Net income + depreciation + amortization + deferred income taxes + other noncash items Or from EBITDA: FFO = EBITDA - interest expense (accrual) - current tax expense But the given formula uses CASH interest and CASH taxes, which is slightly different. Using the given formula: FFO = 1,229M. One more consideration: the "Net Financial Interests" 90M in cash flow vs "Interest Paid" 75M. The 90M includes accrual adjustments. For cash interest, 75M is correct. Final answer: 1,229 / 4,553 = 0.2699 Let me verify my debt calculation once more: - Noncurrent financial liabilities (end 2022): 5,867M - Current financial liabilities (end 2022): 1,022M - Total financial debt: 6,889M - Pension deficit: 248M - Eligible cash: 2,584M - Adjusted debt: 6,889 + 248 - 2,584 = 4,553M ✓ And FFO: - Adjusted EBITDA: 1,505M - Cash interest: 75M - Cash taxes: 201M - FFO: 1,505 - 75 - 201 = 1,229M ✓ Ratio: 1,229 / 4,553 = 0.269931... Rounded: 0.2699 Actually, I want to do one final check. Should I use beginning-of-year or end-of-year debt? Or average? S&P typically uses end-of-period debt for FFO/debt ratio when reporting a specific period's leverage. However, for a more economically accurate measure that matches flow with stock, average debt is sometimes used. Given the problem says "for 2022" and provides both beginning and end balances, and given that debt increased significantly during the year (from 5,068M to 6,889M), using end-of-period might overstate leverage or understate the ratio depending on direction. Actually, FFO/debt is higher (better) with lower debt. End-of-period debt is higher than average, so using end-of-period gives a lower (more conservative) ratio. S&P's published ratios typically use "adjusted debt" at period end. I'll stick with end-of-period. But let me also consider: should I use the debt at the same point as the FFO generation? Since FFO is generated over the year, average debt might be more appropriate. Average debt = (5,068 + 6,889) / 2 = 5,978.5M financial debt Average pension = (294 + 248) / 2 = 271M Average cash = (964 + 2,584) / 2 = 1,774M Average adjusted debt = 5,978.5 + 271 - 1,774 = 4,475.5M FFO / average adjusted debt = 1,229 / 4,475.5 = 0.2746 Difference is small (0.2699 vs 0.2746). Given S&P typically reports end-of-period, I'll use 0.2699. Actually, I realize I should double-check my interpretation of the dates once more. The data shows: - "Cash And Cash Equivalents" 2022-01-01: 964,000,000 EUR - "Cash And Cash Equivalents" 2023-01-01: 2,584,000,000 EUR And for income statement items: - "Revenue From Contracts With Customers" 2022-01-01 - 2023-01-01: 22,946,000,000 EUR So 2022-01-01 to 2023-01-01 is fiscal year 2022. Balance sheet at 2022-01-01 is beginning, at 2023-01-01 is end. For 2022 year-end debt, I should use 2023-01-01 balances. ✓ One final check: are there any other debt-like items I missed? Looking at "Other Noncurrent Liabilities" 370M at end 2022 (up from 129M). This increase might include debt-like items. But without detail, I'll assume these are operational (deferred income, etc.). "Other Longterm Provisions" 729M at end 2022 (down from 797M). These are typically asset retirement obligations, restructuring, etc. S&P sometimes adds AROs to debt if they're material and debt-like. But 729M is not huge, and without knowing the composition, I'll leave as is. Given the baseline formula and lack of specific guidance on these items, I'll use the straightforward calculation. **Final Answer: 0.2699** Wait, I want to do one more verification of my FFO calculation. Let me cross-check using the cash flow. Operating cash flow = 1,260M This includes: - Working capital changes: -1,420M (receivables increase) + 2,587M (payables increase) - 332M (inventory increase) + other = net positive - Other adjustments: -512M If FFO = operating cash flow before working capital changes: Start from operating cash flow 1,260M - Add back working capital uses / subtract working capital sources - Add back other non-FFO items Working capital: receivables -1,420M, payables +2,587M, inventory -332M, other current assets/liabilities changes. Net working capital source = 2,587 - 1,420 - 332 = 835M, plus other items. Actually, from cash flow statement: - Adjustments For Decrease Increase In Trade Account Receivable: -1,420M (use) - Adjustments For Increase Decrease In Trade Account Payable: +2,587M (source) - Adjustments For Decrease Increase In Inventories: -332M (use) - Other Adjustments For Noncash Items: -512M Net of these: -1,420 + 2,587 - 332 - 512 = 323M (source) So operating cash flow before working capital and other = 1,260M - 323M = 937M? That doesn't match FFO of 1,229M. Let me try: FFO should be operating cash flow BEFORE working capital changes and AFTER interest/taxes. From EBITDA 1,505M: - Interest paid: -75M - Taxes paid: -201M - Working capital and other adjustments: various = Operating cash flow 1,260M So FFO (before working capital) = 1,505M - 75M - 201M = 1,229M Then working capital and other = 1,260M - 1,229M = +31M Check: -1,420M + 2,587M - 332M - 512M + other = +31M? -1,420 + 2,587 = 1,167 1,167 - 332 = 835 835 - 512 = 323 That's 323M, not 31M. There's a discrepancy of 292M. Where is this? Looking at other items in cash flow: - Interest Paid: -75M (already in FFO) - Income Taxes Paid: -201M (already in FFO) - Dividends Paid: -302M (this is in operating cash flow!) Ah! The 302M dividends paid are classified as operating activities. If we remove this: Operating cash flow before dividends = 1,260M + 302M = 1,562M Then: 1,562M - 1,229M = 333M, close to 323M (rounding differences). So the reconciliation works if we exclude dividends from operating cash flow. For S&P, dividends paid are typically financing activities. If we reclassify, operating cash flow ex-dividends = 1,562M, and the working capital contribution = 333M. This confirms FFO = 1,229M is consistent with the underlying economics. But wait - should S&P FFO include or exclude dividends paid? Typically FFO is BEFORE dividends. So 1,229M is correct per the formula. However, some S&P calculations treat dividends paid as a use of FFO, not a reduction to FFO. The formula given (FFO = Adjusted_EBITDA - cash_interest - cash_taxes) doesn't include dividends, so 1,229M is correct. Final verification complete. **FFO / Adjusted_Debt = 0.2699** 0.2699